bluebird bio

YTD

ALL

Why Robinhood?

You can watch bluebird bio and buy or sell other stocks, ETFs, and their options commission-free!

About BLUE

bluebird bio, Inc. is a clinical-stage biotechnology company, which engages in researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases. It also offers ZYNTEGLO or beti-cel and SKYSONA or eli-cel gene therapies.

CEO

David D. Meek

CEODavid D. Meek

Employees

248

Employees248

Headquarters

Somerville, Massachusetts

HeadquartersSomerville, Massachusetts

Founded

1992

Founded1992

Employees

248

Employees248

BLUE Key Statistics

Market cap

48.66M

Market cap48.66M

Price-Earnings ratio

-0.24

Price-Earnings ratio-0.24

Dividend yield

—

Dividend yield—

Average volume

193.95K

Average volume193.95K

High today

—

High today—

Low today

—

Low today—

Open price

—

Open price—

Volume

0.00

Volume0.00

52 Week high

$28.60

52 Week high$28.60

52 Week low

$3.20

52 Week low$3.20

People also own

Based on the portfolios of people who own BLUE. This list is generated using Robinhood data, and it’s not a recommendation.